Clay Northam Wealth Management, LLC Edwards Lifesciences Corp Transaction History
Clay Northam Wealth Management, LLC
- $130 Million
- Q2 2024
A detailed history of Clay Northam Wealth Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clay Northam Wealth Management, LLC holds 2,400 shares of EW stock, worth $166,392. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,400
Previous 2,400
-0.0%
Holding current value
$166,392
Previous $229,000
3.49%
% of portfolio
0.17%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding EW
# of Institutions
1,362Shares Held
468MCall Options Held
2.45MPut Options Held
2.56M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.71 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.53 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.8 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.41 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.17 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $42.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...